Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Dickens

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|November 10, 2009
Small-molecule inhibitors of MDM2 as new anticancer therapeuticsMichael P Dickens, Ross Fitzgerald, Peter M Fischer
Carcinogenesis|February 4, 2012
Small molecules that bind the Mdm2 RING stabilize and activate p53Patricia Roxburgh, Andreas K Hock, Michael P Dickens, et al.
Bioorganic & Medicinal Chemistry|October 12, 2013
5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2Michael P Dickens, Patricia Roxburgh, Andreas Hock, et al.
Bioorganic & Medicinal Chemistry|July 28, 2009
Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1Carine Aubry, A James Wilson, Daniel Emmerson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|November 10, 2009
Small-molecule inhibitors of MDM2 as new anticancer therapeuticsMichael P Dickens, Ross Fitzgerald, Peter M Fischer
Carcinogenesis|February 4, 2012
Small molecules that bind the Mdm2 RING stabilize and activate p53Patricia Roxburgh, Andreas K Hock, Michael P Dickens, et al.
Bioorganic & Medicinal Chemistry|October 12, 2013
5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2Michael P Dickens, Patricia Roxburgh, Andreas Hock, et al.
Bioorganic & Medicinal Chemistry|July 28, 2009
Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1Carine Aubry, A James Wilson, Daniel Emmerson, et al.
Pageof 1